Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Healthtrust
AstraZeneca
Queensland Health
Cipla
Johnson and Johnson
Mallinckrodt
Julphar
McKesson
Accenture

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,615,545

« Back to Dashboard

Summary for Patent: 7,615,545
Title:Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
Abstract:This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several combination oral contraceptive regimens in combination with an antidepressant and a kit containing the same.
Inventor(s): Bell; Robert G. (Palm Harbor, FL), Ben-Maimon; Carole (Merion, PA), Iskold; Beata (Livingston, NJ)
Assignee: Duramed Pharmaceuticals, Inc. (Pomona, NY)
Application Number:11/892,014
Patent Claim Types:
see list of patent claims
Use; Delivery; Composition;

Drugs Protected by US Patent 7,615,545

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Teva Branded Pharm LOSEASONIQUE ethinyl estradiol; levonorgestrel TABLET;ORAL 022262-001 Oct 24, 2008 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial PREVENTION OF PREGNANCY ➤ Try a Free Trial
Teva Branded Pharm SEASONIQUE ethinyl estradiol; levonorgestrel TABLET;ORAL 021840-001 May 25, 2006 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial PREVENTION OF PREGNANCY ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,615,545

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,680,084 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology ➤ Try a Free Trial
7,320,969 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology ➤ Try a Free Trial
7,858,605 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology ➤ Try a Free Trial
8,338,396 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,615,545

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2002348272 ➤ Try a Free Trial
Australia 2008237614 ➤ Try a Free Trial
Bulgaria 108736 ➤ Try a Free Trial
Brazil 0214716 ➤ Try a Free Trial
Canada 2468748 ➤ Try a Free Trial
Canada 2655959 ➤ Try a Free Trial
China 100581550 ➤ Try a Free Trial
China 101757628 ➤ Try a Free Trial
China 1599614 ➤ Try a Free Trial
Cyprus 1114421 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Farmers Insurance
Teva
Moodys
Express Scripts
Harvard Business School
Chinese Patent Office
Argus Health
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot